Главная
Рынки
Графики и идеи
Алготрейдинг
Новости
Store
Брокеры
Скачать
Экономический календарь
Торговые сигналы
Вебтерминал
Нажмите
/
для поиска: @user, $symbol, ...
Поиск
Вход
Создать аккаунт
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANGO
#2548
AngioDynamics, Inc.
11.440
0
+1.33%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
Годовой диапазон
Дневное изменение
+1.33%
Месячное изменение
+12.16%
6-месячное изменение
-7.59%
Годовое изменение
-7.59%
Предыдущее закрытие
11.290
0
Open
11.440
0
Bid
Ask
Low
11.440
0
High
11.440
0
Объем
48
Рынки
Рынок акций США
Здравоохранение
ANGO
Open full chart
Financials
Overview
Отчетность
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
38.44 M
38.97 M
39.67 M
40.28 M
40.63 M
—
Valuation ratios
Enterprise value
854.89 M
736.16 M
330.67 M
178.09 M
338.26 M
1.56 B
Price to earnings ratio
-28.65
-28.87
-7.11
-1.37
-11.69
-53.47
Price to sales ratio
3.09
2.42
1.1
0.83
1.35
5.84
Price to cash flow ratio
37.38
-106.44
4 788.26
-9
-39.13
-206.07
Price to book ratio
2.05
1.8
0.99
1.23
2.17
3.97
Enterprise value to EBITDA ratio
-74.45
-536.95
-16.15
-0.81
-20.94
-87.57
Profitability ratios
Return on assets %
0.06
0.05
0.1
0.58
0.12
0.1
Return on equity %
0.07
0.06
0.14
0.9
0.19
0.15
Return on invested capital %
26.01
27.59
48.12
273.77
100.56
78.77
Gross margin %
53.88
52.41
51.44
50.9
53.92
218.3
Operating margin %
12.12
9
15.11
63.32
13.66
42.86
EBITDA margin %
-3.95
-0.43
-6.05
-72.14
-5.52
-19.56
Net margin %
10.84
8.4
15.48
60.66
11.62
36.06
Liquidity ratios
Quick ratio
1.6
1.24
1.29
1.46
1.4
5.51
Current ratio
2.45
1.93
1.95
2.12
2.21
8.95
Inventory turnover
2.47
3.01
3.08
2.57
2.2
2.21
Asset turnover
0.5
0.57
0.62
0.71
0.98
1.11
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.04
0.05
0.09
0
—
—
Long term debt to total equity ratio
0.05
0.06
0.13
0
—
—
Per share metrics
Operating cash flow per share
0.63
0.18
0
0.7
0.25
0.14
EBIT per share
-0.92
-0.73
-1.3
-6.15
-0.98
-0.79
EBITDA per share
-0.3
-0.04
-0.52
-5.46
-0.4
-0.35
Total debt per share
—
—
—
—
—
—
Cash per share
1.26
0.74
1.13
1.89
1.37
4.41
Net current asset value per share
3.67
3.67
4.14
4.81
4.12
16.03
Tangible book value per share
1.8
1.82
2.73
3.19
2.79
10.92
Working capital per share
2.17
1.77
2.02
2.54
2.26
8.86
Book value per share
11.46
10.88
9.58
5.12
4.48
17.62
Новости
Clover Health Q4 Earnings Meet Estimates, Sales Beat, Membership Rises
XRAY Stock Gains Despite Q4 Earnings Miss on Restructuring Initiative
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates
ANGO Expands NanoKnife in Europe for Multi-Organ Tumor Ablation
AngioDynamics расширяет показания для системы NanoKnife в Европе
AngioDynamics expands European indications for NanoKnife system
Here's How Veracyte Stock Is Placed Ahead of Q4 Earnings
Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y
DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth
Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect?
AngioDynamics (ANGO) Down 3.9% Since Last Earnings Report: Can It Rebound?
Here's Why You Should Add Masimo Stock to Your Portfolio Now